BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

718 related articles for article (PubMed ID: 18387776)

  • 21. Sclerotherapy for vascular malformations: complications and a review of techniques to avoid them.
    Odeyinde SO; Kangesu L; Badran M
    J Plast Reconstr Aesthet Surg; 2013 Feb; 66(2):215-23. PubMed ID: 23059134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MR imaging-guided percutaneous sclerotherapy of peripheral venous malformations with a clinical 1.5-T unit: a pilot study.
    Andreisek G; Nanz D; Weishaupt D; Pfammatter T
    J Vasc Interv Radiol; 2009 Jul; 20(7):879-87. PubMed ID: 19481473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retrospective analysis of facial paralysis caused by ethanol sclerotherapy for facial venous malformation.
    Hu X; Chen D; Jiang C; Jin Y; Chen H; Ma G; Lin X
    Head Neck; 2011 Nov; 33(11):1616-21. PubMed ID: 21990226
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ethanol-Gel Sclerotherapy of Venous Malformations: Effectiveness and Safety.
    Teusch VI; Wohlgemuth WA; Hammer S; Piehler AP; Müller-Wille R; Goessmann H; Uller W
    AJR Am J Roentgenol; 2017 Dec; 209(6):1390-1395. PubMed ID: 28929808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes and complications of sclerotherapy for venous malformations.
    Qiu Y; Chen H; Lin X; Hu X; Jin Y; Ma G
    Vasc Endovascular Surg; 2013 Aug; 47(6):454-61. PubMed ID: 23759722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radio-opaque ethylcellulose-ethanol is a safe and efficient sclerosing agent for venous malformations.
    Dompmartin A; Blaizot X; Théron J; Hammer F; Chene Y; Labbé D; Barrellier MT; Gaillard C; Leroyer R; Chedru V; Ollivier C; Vikkula M; Boon LM
    Eur Radiol; 2011 Dec; 21(12):2647-56. PubMed ID: 21822948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sclerotherapy of voluminous venous malformation in head and neck with absolute ethanol under digital subtraction angiography guidance.
    Wang YA; Zheng JW; Zhu HG; Ye WM; He Y; Zhang ZY
    Phlebology; 2010 Jun; 25(3):138-44. PubMed ID: 20483863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bleomycin sclerotherapy for eyelid venous malformations as an alternative to surgery or laser therapy.
    Shigematsu T; Sorscher M; Dier EC; Berenstein A
    J Neurointerv Surg; 2019 Jan; 11(1):57-61. PubMed ID: 29674482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absolute ethanol sclerotherapy for venous malformations in the face and neck.
    Su L; Fan X; Zheng L; Zheng J
    J Oral Maxillofac Surg; 2010 Jul; 68(7):1622-7. PubMed ID: 19962811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bleomycin electrosclerotherapy in therapy-resistant venous malformations of the body.
    Wohlgemuth WA; Müller-Wille R; Meyer L; Wildgruber M; Guntau M; Heydt SV; Pech M; Zanasi A; Flöther L; Brill R
    J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):731-739. PubMed ID: 33045393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous sclerotherapy of massive venous malformations of the face and neck using fibrin glue combined with OK-432 and pingyangmycin.
    Chen WL; Huang ZQ; Zhang DM; Chai Q
    Head Neck; 2010 Apr; 32(4):467-72. PubMed ID: 19672870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bleomycin A5 sclerotherapy for cervicofacial lymphatic malformations.
    Yang Y; Sun M; Ma Q; Cheng X; Ao J; Tian L; Wang L; Lei D
    J Vasc Surg; 2011 Jan; 53(1):150-5. PubMed ID: 20843632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endoscopic transmucosal direct puncture sclerotherapy for management of airway vascular malformations.
    Oomen KP; Paramasivam S; Waner M; Niimi Y; Fifi JT; Berenstein A; O TM
    Laryngoscope; 2016 Jan; 126(1):205-11. PubMed ID: 25970858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peripheral venous malformations with a dominant outflow vein: results of ethanol embolization.
    Rokni-Yazdi H; Ghajarzadeh M; Keyvan AH; Namavar MJ; Azizi S
    Acta Med Iran; 2014; 52(11):868-71. PubMed ID: 25415823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Current concepts in diagnosis and treatment of venous malformations.
    Judith N; Ulrike E; Siegmar R; Matthias N; Jürgen H
    J Craniomaxillofac Surg; 2014 Oct; 42(7):1300-4. PubMed ID: 24969765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative outcomes for sclerotherapy of head and neck venous vascular malformation between alcohol and bleomycin.
    Songsaeng D; Churojana A; Khumthong R; Mahiwan L
    J Med Assoc Thai; 2015 Apr; 98(4):408-13. PubMed ID: 25958717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethanol sclerotherapy of superficial venous malformation: a new procedure.
    Orlando JL; Caldas JG; Campos HG; Nishinari K; Wolosker N
    Dermatology; 2010; 220(4):376-80. PubMed ID: 20484881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ethanol sclerotherapy for the management of craniofacial venous malformations: the interim results.
    Lee IH; Kim KH; Jeon P; Byun HS; Kim HJ; Kim ST; Kim YW; Kim DI; Choi JY
    Korean J Radiol; 2009; 10(3):269-76. PubMed ID: 19412515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Sonographically guided intralesional sclerotherapy for venous malformation].
    Zhang L; Wang J; Zhang CS; Zhou PH; Qian JY; Li XW; Ge SX
    Zhonghua Wai Ke Za Zhi; 2008 Oct; 46(19):1472-4. PubMed ID: 19094624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and effectiveness of percutaneous sclerotherapy for venous disorders of the labia majora in patients with vascular malformations.
    Brill R; Deistung A; Gussew A; Goldann C; Stangl F; Uller W; Rosendahl J; Wildgruber M; Wohlgemuth WA
    J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1083-1089. PubMed ID: 32199800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.